Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics

Author:

Henry Zoé1,Villar Fimbel Sylvie1,Bendelac Nathalie12,Perge Kevin2,Thivolet Charles1ORCID

Affiliation:

1. Centre for Diabetes DIAB‐eCARE Hospices Civils de Lyon Lyon France

2. Department of paediatric Endocrinology and Diabetes Hospices Civils de Lyon Bron France

Abstract

AbstractAimTo investigate glycaemic outcomes in youths and adults with type 1 diabetes with either MiniMed™ 780G or Tandem t:slim X2™ control‐IQ automated insulin delivery (AID) systems and to evaluate clinical factors that migrate, mitigate the achievement of therapeutic goals.Materials and MethodsThis retrospective, real‐world, observational study was conducted in a specialized university type 1 diabetes centre with patients observed for 3‐12 months post‐initiation of an AID system. Primary outcomes were the percentage time in the target glucose range [TIR70‐180 mg/dl (3.9‐10 mmol/L)] as measured by continuous glucose monitoring, mean glucose management indicator (GMI) and glycated haemoglobin (HbA1c) levels.ResultsOur study cohort consisted of 48 adolescents and 183 adults (55% females) aged 10‐77 years. The mean (95% confidence interval) TIR70‐180 mg/dl after 30 days was higher than baseline and by 14% points after 360 days with 71.33% (69.4‐73.2) (n = 123, p < .001). HbA1c levels decreased by 0.7% and GMI by 0.6% after 360 days. The proportion of time spent <70 mg/dl (3.9 mmol/L) was not significantly different from baseline. During follow‐up, 780G users had better continuous glucose monitoring results than control‐IQ users but similar HbA1c levels, and an increased risk of weight gain. Age at onset influenced TIR70‐180 mg/dl in univariate analysis but there was no significant relationship after adjusting on explanatory variables. Baseline body mass index did not influence the performance of AID systems.ConclusionsThis analysis showed the beneficial effects of two AID systems for people with type 1 diabetes across a broad spectrum of participant characteristics. Only half of the participants achieved international recommendations for glucose control with TIR70‐180 mg/dl >70%, HbA1c levels or GMI <7%, which outlines the need to maintain strong educational and individual strategies.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3